Literature DB >> 27652783

Drug development: Through the barrier.

Sarah DeWeerdt.   

Abstract

Mesh：

Year:  2016        PMID： 27652783     DOI： 10.1038/537S154a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Heat shock protein-based therapy as a potential candidate for treating the sphingolipidoses.

Authors:  Thomas Kirkegaard; James Gray; David A Priestman; Kerri-Lee Wallom; Jennifer Atkins; Ole Dines Olsen; Alexander Klein; Svetlana Drndarski; Nikolaj H T Petersen; Linda Ingemann; David A Smith; Lauren Morris; Claus Bornæs; Signe Humle Jørgensen; Ian Williams; Anders Hinsby; Christoph Arenz; David Begley; Marja Jäättelä; Frances M Platt
Journal:  Sci Transl Med       Date:  2016-09-07       Impact factor: 17.956
  1 in total
  2 in total

Review 1.  Lysosomal size matters.

Authors:  Mariana E G de Araujo; Gudrun Liebscher; Michael W Hess; Lukas A Huber
Journal:  Traffic       Date:  2019-12-06       Impact factor: 6.215

2.  Enzyme replacement therapy and white matter hyperintensity progression in Fabry disease.

Authors:  James D Stefaniak; Laura M Parkes; Adrian R Parry-Jones; Gillian M Potter; Andy Vail; Ana Jovanovic; Craig J Smith
Journal:  Neurology       Date:  2018-09-12       Impact factor: 9.910
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.